TORONTO DOMINION BANK - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
TORONTO DOMINION BANK ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$806
+80500.0%
90.0%0.00%
Q2 2023$1
-100.0%
9
-99.9%
0.00%
-100.0%
Q1 2022$480,0007,600
+253233.3%
0.00%
Q4 2021$0
-100.0%
3
-99.0%
0.00%
Q4 2020$36,000
+38.5%
3000.0%0.00%
Q3 2020$26,000
-3.7%
3000.0%0.00%
Q2 2020$27,0003000.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2021
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders